Previous studies showed that EIF3J-AS1 can exert its cancer-promoting effects by upregulating the expression of target genes, such as AKT1, YAP1 and ANXA118-10, via competing endogenous RNA22, 23. The gene discussed is AKT1; the disease is cancer.